🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

China Gender-affirming Hormone Therapy Study

Recruitingn/aAges 18 Years - 40 YearsAllPeking University Third Hospital
NCT05318755 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Data about transgender medical care, especially the gender-affirming hormone therapy (GAHT) is extremely insufficient in China. Few evidence exists in the physical and psychological effects of the hormonal treatment in Chinese transgender population. CGAHT is designed to describe the social and mental condition of transgender people who are seeking for formal GAHT, and to investigate the physical and psychological effects of GAHT on this population in China.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Transgender men and women * Meet criteria of Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) for gender dysphoria * Aged between 18 to 40 years * People desire to start the GAHT * No previous history of gender-affirming interventions * Having full ability to make informed consent * Dextromanual Exclusion Criteria: * Disorders of sex development * Who has fertility demand but have not made fertility preservation * With contradictions of GAHT * Comorbid diseases are not under control * Alcohol or drug abuse * Hormonal and chromosomal disorders * History of gender affirming surgery * Current psychiatric disorders * History of brain trauma or neurological pathologies * Current use of medications with psychotropic effects within two weeks (antipsychotic or antiepileptic agents, lithium, benzodiazepines or opioid analgesics) * Claustrophobia * Implanted metal and medical devices (pacemakers, ceramic teeth, etc.), * Tattoos or eyebrow tattooing (heavy metal dye)
💊

What it tests

  • GAHT for transgender men
  • GAHT for transgender women
📍

Where

1 site
Peking University Third Hospital
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy